Background Chagas disease (CD) is a neglected disease affecting millions worldwide, yet
little is known about its economic burden. This systematic review is part of RAISE project, a …

Objective To quantify the costs of Chagas disease in Colombia from a societal perspective in
2017. Methods A cost-of-illness analysis was carried out using a prevalence-based …

Resumen VALLEJO, Maite; MONTENEGRO, Pablo y REYES, Pedro A. How much does the
medical treatment of chronic chagasic cardiopathy cost?: Direct costs in a cardiology referral …

Chagas disease was discovered in 1909 by the Brazilian scientist Carlos Chagas. After
more than 110 years, many outcomes have been achieved in all research fields; however …

Summary Background As Chagas disease continues to expand beyond tropical and
subtropical zones, a growing need exists to better understand its resulting economic burden …

Background: Chagas disease (CD) is a neglected tropical disease, endemic in Latin
America, but due to migration and environmental changes it has become a global public …

Chagas cardiomyopathy (CC), caused by the protozoan Trypanosoma cruzi, is an important
cause of cardiovascular morbidity and mortality in developing countries. It is estimated that 6 …

Background The clinical outcomes associated with Chagas disease remain poorly
understood. In addition to the burden of morbidity, the burden of mortality due to …

More than 100 years have elapsed since the first description of human American
trypanosomiasis by the Brazilian scientist Carlos Chagas; however, this neglected disease …

Chagas disease, caused by infection with the protozoa Trypanosoma cruzi is transmitted
most often by Triatominae insect vectors, but also through blood transfusion, organ …